Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Drug Delivery

Dual-scaffold imageable embolic system with microenvironment normalization enhances hypoxia-activated chemoembolization for HCC

  1. 1Shanghai Eighth People's Hospital, Shanghai, China
  2. 2School of Pharmacy, Jiangsu University, Zhenjiang, China
  3. 3Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Abstract

Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) is limited by the post-embolization tumor microenvironment (pE-TME), which drives revascularization and fibrosis, thereby narrowing the hypoxic window and restricting drug penetration for hypoxia-activated prodrugs like tirapazamine (TPZ). To overcome this challenge, we developed a dual-scaffold theranostic platform integrating an iodinated thermosensitive PNIPAM hydrogel with genipin-crosslinked albumin microspheres for the coordinated co-delivery of nintedanib (NIB) and TPZ. This platform provides intrinsic X-ray visibility, rapid in situ gelation, enhanced mechanical strength, and sustained drug release with excellent hemocompatibility. In vitro, released NIB inhibited fibroblast proliferation, while TPZ potently induced apoptosis in hypoxic HCC cells. In vivo, the platform enabled stable vascular occlusion and prolonged tumor retention. In an orthotopic HCC model, the dual-drug combination achieved 91% tumor inhibition, significantly outperforming embolization alone and single-drug groups, without systemic toxicity. Mechanistically, TPZ promoted apoptosis (Caspase-3/Ki-67), whereas NIB suppressed compensatory angiogenesis (VEGF/CD31) and collagen deposition (α-SMA), thereby remodeling the pE-TME to stabilize hypoxia. By converting the therapy-limiting hypoxic microenvironment into a therapeutic asset, this dual-scaffold strategy offers a new paradigm for amplifying TACE efficacy.

Related

  1. Polydopamine-mediated curcumin-functionalized electroactive nanofibrous scaffold accelerates infected wound healing via multifactorial microenvironment remodeling.
    Mintao Tian, Yuntian Bai, Zhongdi Liu +6
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  2. Near-infrared-activated CuTA@PDA@PTH nanozymes remodel the osteoarthritic microenvironment for coordinated cartilage protection and subchondral bone repair.
    Zhao Lin, Jiayao Zhang, Mingjuan Zhang +9
    Journal of nanobiotechnologyPeer-reviewedCC BY-NC-NDFull textSystems & synthetic biologyGeneral medicineEurope PMCDOAJ
  3. Long-Term Outcomes of Interventional Treatments for Lung Cancer Liver Metastases: Transarterial Chemoembolization and Microwave Ablation
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Drug-eluting bead transarterial chemoembolization with immunotherapy and targeted therapy for advanced clear cell renal cell carcinoma: A case report.
    Yin Gao, Qiang Xu, Dongxu Kang +1
    Oncology lettersPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Case Report: Rapidly fatal hepatic portal venous gas following transarterial chemoembolization for hepatocellular carcinoma
    Renshan Zhao, Bin Xie
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
BibTeX
@article{qi2026dualscaffold,
  title = {{Dual-scaffold imageable embolic system with microenvironment normalization enhances hypoxia-activated chemoembolization for HCC}},
  author = {Zhong Qi and Shanqin Huang and Feng Xiao and Kai Yang and Ying Xu and Wang Yao and Jun Cao},
  journal = {Drug Delivery},
  year = {2026},
  month = nov,
  doi = {10.1080/10717544.2026.2758558},
  url = {https://doi.org/10.1080/10717544.2026.2758558},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Dual-scaffold imageable embolic system with microenvironment normalization enhances hypoxia-activated chemoembolization for HCC
AU  - Zhong Qi
AU  - Shanqin Huang
AU  - Feng Xiao
AU  - Kai Yang
AU  - Ying Xu
AU  - Wang Yao
AU  - Jun Cao
PY  - 2026
DA  - 2026/11/10
JO  - Drug Delivery
DO  - 10.1080/10717544.2026.2758558
UR  - https://doi.org/10.1080/10717544.2026.2758558
AB  - Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) is limited by the post-embolization tumor microenvironment (pE-TME), which drives revascularization and fibrosis, thereby narrowing the hypoxic window and restricting drug penetration for hypoxia-activated prodrugs like tirapazamine (TPZ). To overcome this challenge, we developed a dual-scaffold theranostic platform integrating an iodinated thermosensitive PNIPAM hydrogel with genipin-crosslinked albumin microspheres for the coordinated co-delivery of nintedanib (NIB) and TPZ. This platform provides intrinsic X-ray visibility, rapid in situ gelation, enhanced mechanical strength, and sustained drug release with excellent hemocompatibility. In vitro, released NIB inhibited fibroblast proliferation, while TPZ potently induced apoptosis in hypoxic HCC cells. In vivo, the platform enabled stable vascular occlusion and prolonged tumor retention. In an orthotopic HCC model, the dual-drug combination achieved 91% tumor inhibition, significantly outperforming embolization alone and single-drug groups, without systemic toxicity. Mechanistically, TPZ promoted apoptosis (Caspase-3/Ki-67), whereas NIB suppressed compensatory angiogenesis (VEGF/CD31) and collagen deposition (α-SMA), thereby remodeling the pE-TME to stabilize hypoxia. By converting the therapy-limiting hypoxic microenvironment into a therapeutic asset, this dual-scaffold strategy offers a new paradigm for amplifying TACE efficacy.
SN  - 1071-7544
SN  - 1521-0464
ER  -